MENUCLOSE

 

What Do You Do When You Don’t Have Enough Clinical Trial Locations: Interview with Krystyna Kowalczyk of Oncobay

by ArcheMedX Team Mar 18 , 2021 3 min read

Krystyna Kowalczyk joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss innovation and leadership in oncology clinical trials.

The founder and CEO of OncoBay Clinical, Krystyna shares her efforts to break the mold when it comes to cancer research, and explores OncoBay’s “just in time” enrollment model and why investing up-front in site preparedness is critical to impacting clinical research.

Enjoy this interview by video below, or by subscribing to our podcast on Simplecast, Spotify, or iTunes.

Krystyna Kowalczyk

Krystyna Kowalczyk is the CEO and President of OncoBay Clinical. The boutique CRO is not the first company she’s founded. She began her career in drug-device combination work but soon made the move to the CRO side, where she saw plenty of potential for making a significant impact in the research space.

It was Krystyna’s clear-eyed assessment of the industry that drove her to found OncoBay Clinical. Determined to build a fresh, modern CRO worthy of the ever-evolving oncology field, Krystyna and her team embraced an innovative approach to how digital tools and predictive analytics could change the research paradigm.

The willingness to constantly evaluate and adapt is fundamental to their work advancing immuno-oncology research.

Episode Highlights

  • The three tenets of OncoBay’s approach to cutting-edge cancer research
  • How to prepare staff for the complexities of a 21st-century oncology trial
  • Why we need to evolve from serial to real-time data assessment 
  • OncoBay’s “just-in-time” enrollment model (and a touching success story)
  • Why investing up-front in site preparedness is critical to maximizing impact in research
  • How the just-in-time model can help address diversity challenges in enrollment
  • Why new technologies and methodologies often create discomfort, and what leaders can do about it
  • How you can make 1 + 1 equal 3 when you combine tools effectively
  • Why putting together the right team is both more challenging and more critical than putting together the technology
  • What Krystyna looks for when assessing potential team members 
  • Why she’s excited for the next generation of industry employees

Resources:

Oncobay
Find Oncobay on LinkedIn
Conversations in Clinical Trial Readiness Interview Series

Related Post

3 min Read 1 Mar, 2022

Decentralized trials (DCTs) at Risk, or Ready?

It should come as little surprise that the rise in decentralized trials (DCTs) and increase…

ArcheMedX Team
ArcheMedX Team
2 min Read 27 Jan, 2022

Meeting the ArcheMedX Team at SCOPE 2022

How can you minimize the performance risks given the complexities of a clinical trial and…

ArcheMedX Team
ArcheMedX Team
3 min Read 9 Dec, 2021

Pandemic Impact on Clinical Trial Recruitment with Atul Mahableshwarkar, M.D., DFAPA

Atul Mahableshwarkar, M.D., DFAPA, joins Kelly Ritch, EVP of Product and Clinical Research Solutions at…